Low 30-day Mortality after Atrial Fibrillation Ablation; Results from the Netherlands Heart Registration: NHR-AF Mortality Study

Daniel Mol*, Michelle D van der Stoel, Jippe C Balt, Rohit E Bhagwandien, Yuri Blaauw, Pascal F H M van Dessel, Vincent J H M van Driel, Antoine H G Driessen, Arif Elvan, Rutger J Hassink, Michiel J B Kemme, Karin Kraaier, Wichert J Kuijt, Justin G L M Luermans, Pepijn H van der Voort, Sjoerd W Westra, Joris R de Groot, Jonas S S G de Jong

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

51 Downloads (Pure)

Abstract

This study presents the 30-day mortality of patients who underwent atrial fibrillation (AF) ablation between 2013 - 2020 and were registered in the Netherlands Heart Registration. In total, 30,197/30,238 (99.9%) patients were analyzed. Fifteen (0.05%) died within 30 days. Nine deaths were considered procedurally related, four were considered non-procedural related, and in two patients the cause of death was unknown.

Original languageEnglish
Pages (from-to)1616-1618
Number of pages3
JournalCanadian Journal of Cardiology
Volume38
Issue number10
Early online date13 Jun 2022
DOIs
Publication statusPublished - Oct 2022

Fingerprint

Dive into the research topics of 'Low 30-day Mortality after Atrial Fibrillation Ablation; Results from the Netherlands Heart Registration: NHR-AF Mortality Study'. Together they form a unique fingerprint.

Cite this